Psychosomatic Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published online before print , 10.1097/PSY.0b013e31803130ae
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilson, R. S.
Right arrow Articles by Bennett, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilson, R. S.
Right arrow Articles by Bennett, D. A.

Terminal Cognitive Decline: Accelerated Loss of Cognition in the Last Years of Life

Robert S. Wilson, PhD, Todd L. Beck, MS, Julia L. Bienias, ScD and David A. Bennett, MD

From the Rush Alzheimer’s Disease Center (R.S.W., D.A.B.) and Rush Institute for Healthy Aging (T.L.B., J.L.B.) and the Departments of Neurological Sciences (R.S.W., D.A.B.), Behavioral Sciences (R.S.W.), and Internal Medicine (J.L.B.), Rush University Medical Center, Chicago, IL.


Figure 13
View larger version (12K):
[in this window]
[in a new window]

 
Figure 1. Log-likelihood, an indicator of goodness of fit, from a series of analyses allowing terminal decline to begin at different points before death in global cognition (upper left), episodic memory (upper right), semantic memory (middle left), working memory (middle right), perceptual speed (lower left), and visuospatial ability (lower right).

 

Figure 23
View larger version (5K):
[in this window]
[in a new window]

 
Figure 2. Predicted 5-year paths of change for two typical participants, one who survived (solid line) and one who died after 5 years (dotted line).

 

Figure 33
View larger version (16K):
[in this window]
[in a new window]

 
Figure 3. Predicted paths of global cognitive decline in those who died (upper panel) and an equal number of persons randomly selected from survivors (lower panel).

 

Figure 43
View larger version (6K):
[in this window]
[in a new window]

 
Figure 4. Predicted 5-year paths of change in global cognition for two typical participants who died after 5 years, one with (dotted line) and one without (solid line) an apolipoprotein E {varepsilon}4 allele.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Psychosomatic Society